CLINICAL_TRIALS
trial_result
· 2017-09-05
Clinical Trial Update: Efficacy and Safety Study of Drugs for Treatment of Visceral Leishmaniasis in Brazil [Phase 4]
Summary
A Phase 4 clinical trial evaluating efficacy and safety of drugs for visceral leishmaniasis in Brazil was terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of Brasilia | Conditions: Visceral Leishmaniasis | Phase 4 | Status: TERMINATED